Strategic Growth Drivers Shaping the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Outlook 2025- 2034:Growing Prevalence of Respiratory Diseases on COPD and Asthma Devices
Discover trends, market shifts, and competitive outlooks for the chronic obstructive pulmonary disease (copd) and asthma devices industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
How Fast Is The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Expected to Grow Between 2025 And 2029?
In recent times, there’s been a remarkable growth in the size of the market for devices used in the handling of chronic obstructive pulmonary disease (COPD) and asthma. The market value is projected to increase from $44.95 billion in 2024 to $47.83 billion in 2025 with a 6.4% compound annual growth rate (CAGR). The growth witnessed during the historic period can be credited to factors such as the rise in the elderly population, increased allergy incidences, enhanced government initiatives, an upsurge in clinical research and trials, as well as increased urbanization.
The market size for devices associated with chronic obstructive pulmonary disease (COPD) and asthma is anticipated to experience significant expansion in the upcoming years. By 2029, its expected value is $60.53 billion, with a compound annual growth rate (CAGR) of 6.1%. Factors contributing to this projected growth throughout the forecast period include increased instances of respiratory illnesses, a surge in cigarette smoking, growth in environmental pollution levels and respiratory problems, an increase in the prevalence of respiratory diseases, higher healthcare expenses, and a rise in the portability of drug delivery devices. Key trends expected during the forecast period encompass technological evolution, the incorporation of smart technology, personalized healthcare, the adoption of biologics, and the use of wearable breathing monitors.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18298&type=smp
Which Factors and External Forces Are Driving Demand in the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
The escalating incidence of diseases that impact the respiratory system is projected to drive expansion in the market for Chronic Obstructive Pulmonary Disease (COPD) and asthma devices. Conditions such as asthma, COPD, pneumonia, and lung cancer, which disrupt normal respiratory function, form part of the broader spectrum of respiratory diseases. The surge in these diseases can be attributed to mounting levels of air pollution, shifts in climatic trends influencing allergens and pathogens, as well as lifestyle choices like smoking that adversely affect respiratory wellbeing. In the holistic management and treatment of respiratory diseases, COPD and asthma devices play a pivotal role, aiding individuals in achieving improved respiratory health, subsequently enhancing their overall quality of life. For example, the World Health Organization (WHO) reported in March 2023 that COPD stood as the third highest cause of death worldwide, accountable for roughly 3.23 million mortalities. Additionally, about 90% of these deaths affecting individuals younger than 70 occurred in low- and middle-income countries (LMICs). Consequently, the escalating incidence of respiratory diseases stimulates the growth of markets for Chronic Obstructive Pulmonary Disease (COPD) and asthma devices.
Which Segments in the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Offer the Most Growth?
The chronic obstructive pulmonary disease (COPD) and asthma devices market covered in this report is segmented –
1) By Type: Metered Dose Inhalers, Drug Powder Inhalers, Soft Mist Inhalers, Jet Nebulizers, Ultrasonic Nebulizers, Other Types
2) By Indication: Asthma, Chronic Obstructive Pulmonary Disease
3) By Application: Hospitals, Clinics, Home Care Settings, Research Institutions, Other Applications
4) By End User: Pediatric, Adult, Geriatric
Subsegments:
1) By Metered Dose Inhalers: Conventional MDI, Breath-Actuated MDI
2) By Drug Powder Inhalers: Dry Powder Inhalers (DPI), Multi-Dose DPI
3) By Soft Mist Inhalers: Respimat Soft Mist Inhalers, Other Soft Mist Devices
4) By Jet Nebulizers: Pneumatic Nebulizers, Venturi-Type Nebulizers
5) By Ultrasonic Nebulizers: Tabletop Ultrasonic Nebulizers, Portable Ultrasonic Nebulizers
6) By Other Types: Nebulizer Accessories, Spacer Devices
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=18298&type=smp
What Are the Fastest-Growing Geographies in the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
North America was the largest region in the chronic obstructive pulmonary disease (COPD) and asthma devices market in 2023. The regions covered in the chronic obstructive pulmonary disease (COPD) and asthma devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Trends Are Shaping the Future of the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
Leading businesses in the market for Chronic Obstructive Pulmonary Disease (COPD) and asthma devices are shifting their focus towards the development of novel technologies such as inhalation devices. These devices feature integrated digital health capabilities that allow for remote monitoring and customized treatment management. Devices for inhalation serve as a medium to directly administer medicine into the lungs by inhalation. In May 2022, Alkem Laboratories, a pharmaceutical company based in India, launched the Innohaler, a dry powder inhaler device, to simplify life for COPD and asthma patients. The Innohaler takes advantage of highly advanced breath-actuated technology, the benefits of which include accurate medication delivery, optimized dosage, and a decrease in wastage. Furthermore, its ergonomic style results in ease of use, with an easy-to-understand interface that caters to patients of all age groups. The device’s design is compact and portable, ensuring that it’s convenient for users who are always on the move, and increases patient compliance with prescribed therapies.
View the full report here:
What Are the Key Elements That Define the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
Chronic obstructive pulmonary disease (COPD) and asthma devices refer to the medical devices used to manage and treat breathing and respiratory conditions. These devices help patients breathe more effectively, manage symptoms, and improve their quality of life.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18298
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
